Medical treatment alone for symptomatic free-floating thrombus of the carotid artery showed promising results with low 30-day stroke rates and thrombus dissolution, though the level of evidence remains low and large-scale prospective studies are needed.
Free-floating thrombus (FFT) accounts for approximately 1.3% of all ischemic stroke cases.
In the authors' case series of 4 patients with symptomatic carotid FFT treated solely with medical therapy, no ischemic stroke recurrence occurred within 30 days and complete thrombus resolution was achieved.
A literature review of 349 patients with ischemic stroke symptoms and extracranial carotid FFT found that 272 patients were treated exclusively with medical therapy.
Recurrent 30-day stroke was experienced by 22 (8.1%) of the 272 patients treated exclusively with medical therapy.
The European Society for Vascular Surgery (ESVS) guidelines recommend anticoagulation therapy for patients with acute stroke secondary to carotid FFT and suggest considering invasive intervention if recurrence occurs during anticoagulation therapy.
The limited number of cases and the predominance of retrospective studies or case reports highlight the need for large-scale prospective studies on carotid FFT management.
This research suggests that a dangerous blood clot condition called a free-floating thrombus (FFT) in the carotid artery — where a clot is partially attached to the artery wall with blood still flowing around it — can be successfully treated with medication alone, without the need for surgery. In their own group of 4 patients who had stroke symptoms caused by this type of clot, the researchers found that all patients recovered without having another stroke within 30 days, and the clots fully dissolved with medical treatment. A review of 20 published studies covering 349 similar patients found that about 8% of the medically treated patients had a recurrent stroke within 30 days, which the authors consider a relatively low rate. The most commonly used medication in the reviewed studies was anticoagulation (blood thinners), which was used in over half of medically managed patients. Current European vascular surgery guidelines support anticoagulation as the primary treatment, with surgery or other invasive procedures recommended only if a patient has another stroke despite being on blood thinners. The researchers emphasize that treatment decisions should be individualized, taking into account the cause of the clot, the patient's stroke history, how much time has passed since the stroke, the size of any brain damage, where the clot is located, and how the clot appears on follow-up imaging. This research matters because FFT is rare and poorly understood, accounting for only about 1% of all stroke cases, meaning doctors have limited high-quality guidance on how to treat it. The findings suggest that medication alone may be sufficient for many patients, potentially sparing them from the risks of invasive procedures. However, the authors caution that almost all existing studies — including this one — are small and retrospective, meaning the results should be interpreted carefully. Large, well-designed prospective studies are urgently needed to establish clearer, more reliable treatment recommendations.
Shehab M, Ponansky F, Sivan Hoffman R, Bachar A. (2026). [Medical Management Alone in Symptomatic Free-Floating Thrombus of the Carotid Artery].. Harefuah. https://pubmed.ncbi.nlm.nih.gov/42687256/